Showing results (41-50 of 117) with videos related to
Sort By:
Pageof 12
Cancer|September 21, 2016
Whole-exome sequencing and targeted gene sequencing provide insights into the role of PALB2 as a male breast cancer susceptibility geneValentina Silvestri, Veronica Zelli, Virginia Valentini, et al.NPJ Digital Medicine|January 3, 2026
Powering responsible artificial intelligence with high-quality real-world data: the S-RACE platform for scalable, multi-specialty clinical researchAlberto Traverso, Donato Tiano, Andrea Corvaglia, et al.Cancer Medicine|August 28, 2024
Atypical cancer risk profile in carriers of Italian founder BRCA1 variant p.His1673del: Implications for classification and clinical managementGiovanni Innella, Cristina Fortuno, Laura Caleca, et al.La Radiologia Medica|August 29, 2022
AI-SCoRE (artificial intelligence-SARS CoV2 risk evaluation): a fast, objective and fully automated platform to predict the outcome in COVID-19 patientsAnna Palmisano, Davide Vignale, Edda Boccia, et al.Breast Cancer Research and Treatment|October 9, 2003
Different expressivity of BRCA1 and BRCA2: analysis of 179 Italian pedigrees with identified mutationPaolo Aretini, Emma D'Andrea, Barbara Pasini, et al.European Journal of Human Genetics : EJHG|February 2, 2017
Evaluation of copy-number variants as modifiers of breast and ovarian cancer risk for BRCA1 pathogenic variant carriersLogan C Walker, Louise Marquart, John F Pearson, et al.Breast Cancer Research and Treatment|September 27, 2012
Evaluation of chromosome 6p22 as a breast cancer risk modifier locus in a follow-up study of BRCA2 mutation carriersKristen N Stevens, Xianshu Wang, Zachary Fredericksen, et al.European Journal of Human Genetics : EJHG|August 24, 2018
Correction: Evaluation of copy-number variants as modifiers of breast and ovarian cancer risk for BRCA1 pathogenic variant carriersLogan C Walker, Louise Marquart, John F Pearson, et al.Clinical Chemistry|November 12, 2013
Comparison of mRNA splicing assay protocols across multiple laboratories: recommendations for best practice in standardized clinical testingPhillip J Whiley, Miguel de la Hoya, Mads Thomassen, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 16, 2014
Germline mutation in BRCA1 or BRCA2 and ten-year survival for women diagnosed with epithelial ovarian cancerFrancisco J Candido-dos-Reis, Honglin Song, Ellen L Goode, et al.Pageof 12